Clay Guynn, DO
Physical Medicine & Rehabilitation · Lexington, KYNPI 1699180398
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $117,531 of the $192,746 with a category attached, or 61.0%. Pacira Pharmaceuticals Incorporated accounts for 98.7% of it on its own, with 22 other manufacturers making up the rest. Among physical medicine & rehabilitation clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 720 payments — averaging $267.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$190K
- AbbVie$419
- Amgen$354
- Linkbio Corp$271
- Bioventus LLC$261
- Avanos Medical$228
- plus $927 from 17 others
What the payments were for
- Consulting fees$117,53161%
- Speaking & faculty fees$25,99013%
- Travel & lodging$35,92619%
- Food & beverage$13,2887%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 622 | $190,285 |
| AbbVie(2 entities) | 18 | $419 |
| Amgen | 27 | $354 |
| Linkbio Corp | 1 | $271 |
| Bioventus LLC | 9 | $261 |
| Avanos Medical | 5 | $228 |
| Pacira Therapeutics, Inc. | 12 | $217 |
| Vertex | 5 | $148 |
| Abbott | 2 | $134 |
| Averitas Pharma Inc. | 1 | $68 |
| Ipsen Biopharmaceuticals, Inc | 3 | $61 |
| Hydrocision, Inc. | 2 | $52 |
| SPR Therapeutics, Inc | 3 | $49 |
| United Orthopedics LLC | 1 | $32 |
| Kerecis Limited | 1 | $25 |
| Innovation Technologies Inc | 1 | $23 |
| Radius Health, Inc. | 1 | $21 |
| Sanara Medtech Inc. | 1 | $20 |
| GRT US Holding, Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$192,746 in reported general payments places this provider in the 95th percentile of 104 physical medicine & rehabilitation providers in Kentucky.
See all physical medicine & rehabilitation providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 53 | $684 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $278 |
| Tizanidine Hcl | 11 | $97 |
| Methocarbamol | 11 | $70 |
| Tramadol Hcl | 20 | $69 |
| Diazepam | 43 | $28 |
| Meloxicam | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Lexington
- Raechel PercyLexington$8K
- Melanie LedfordLexington$6K
- Cecil HollenLexington$4K
- Stephen PorterLexington$4K
- Nicholas ElwertLexington$3K
- Jamie KeyLexington$3K
- Michael ParrottLexington$2K
- Christopher JamesLexington$2K
- Derek DixonLexington$2K
- Jessica KavanaughLexington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.